Additionally, nesfatin-1 was observed to be augmented in gastric cancer and exerts a decent role in diagnosing gastric cancer (Area Under the Curve (AUC) = 0.857, 95% CI 0.769–0.946) with a threshold of 1.075 ng/ml (61). This evidence concerns the gene NUCB2 and gastric cancer.